Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Carbapenem from Merck & Co. undergoing extensive evaluation

Oct. 4, 1996

P&G describes quinolonyl-cephem dithiocarbamates

Oct. 4, 1996

Cephalosporin-bridged carbacephem combinations evaluated by Roche

Oct. 4, 1996

Combined beta-lactamase inhibitor/antibacterial agent from Roche

Oct. 4, 1996

Bridged carbacephems from Roche for use in combination with cephalosporins

Oct. 4, 1996

Fujisawa describes orally active cephalosporin

Oct. 4, 1996

Hydroxypyridone cephalosporins described by Kyorin

Oct. 4, 1996

New antiacne bacteriocin

Oct. 4, 1996

Yamanouchi reports agent for urinary incontinence

Sep. 27, 1996

gpIIb/IIIa antagonist selected for clinical evaluation at DuPont Merck

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...